The long-term effects of the Covid-19 infection on cardiac symptoms
Reza Golchin Vafa1,2, Reza Heydarzadeh1,2, Mohammadhossein Rahmani2
1Cardiology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Insights
Long COVID can cause lasting cardiovascular issues, with dyspnea being the most common symptom a year after infection. Hospitalized patients experienced more major adverse cardiac events, highlighting the need for ongoing cardiovascular monitoring post-COVID-19.
Area of Science:
- Cardiology
- Infectious Diseases
- Public Health
Background:
- Coronavirus disease 2019 (COVID-19) is known to affect multiple organ systems beyond the lungs, including the cardiovascular system.
- Long-term complications of COVID-19 are increasingly recognized, necessitating further investigation into persistent symptoms.
Purpose of the Study:
- To assess the prevalence and characteristics of long-term cardiovascular symptoms in patients one year after COVID-19 infection.
- To identify risk factors associated with persistent cardiovascular issues and major adverse cardiac events (MACE) following COVID-19.
Main Methods:
- A retrospective cohort study was conducted involving patients from an outpatient cardiovascular clinic in Shiraz, Iran.
- Data were collected from October 2020 to May 2021, including patient history of COVID-19 at least one year prior, current symptoms (dyspnea, chest pain, fatigue, palpitations), and incidence of MACE.
Main Results:
- The most frequent long-term cardiovascular symptoms included exertional dyspnea (51.2%), dyspnea at rest (41.6%), fatigue (39%), and chest pain (27.1%).
- Symptoms were more prevalent in patients who had been hospitalized for COVID-19.
- The overall incidence of MACE was 6.1% during the 12-month follow-up, with higher rates observed in previously hospitalized patients or those with comorbid conditions.
Conclusions:
- A significant prevalence of cardiovascular symptoms persists one year after COVID-19 infection, with dyspnea being the most common.
- Hospitalization for COVID-19 is associated with an increased risk of MACE, underscoring the importance of cardiovascular surveillance in these patients.
Background:
Besides the lungs, coronavirus disease 2019 (COVID-19) can affect the cardiovascular, digestive, urinary, hepatic, and central nervous systems. Other than its short-term effects, COVID-19 may also cause long-term complications. In this study, we assessed long-term COVID-19 cardiovascular symptoms among patients in a cardiovascular clinic.
Method:
A retrospective cohort was conducted between October 2020 to May 2021 on patients at an outpatient cardiovascular clinic in Shiraz, Iran. Patients with a history of COVID-19 at least one year before their referral were included. Baseline information was extracted from the clinic's database. Data were collected regarding symptoms like dyspnea, chest pain, fatigue, and palpitations after a year of COVID-19. We also noted any major adverse cardiac events (MACE).
Results:
Most common symptoms after a year of COVID-19 were exertional dyspnea (51.2%), dyspnea at rest (41.6%), fatigue (39%), and chest pain (27.1%). The symptoms were more prevalent in hospitalized patients than in non-hospitalized patients. The prevalence of MACE was about 6.1% during the 12-month follow-up, with this rate being higher in those with a history of hospitalization or comorbid diseases.
Conclusion:
The prevalence of cardiovascular symptoms was fairly high in patients at our clinic a year after COVID-19, and the most common symptom was dyspnea. Hospitalized patients had more MACE. (Clinicaltrial.gov number: NCT05715879)(04/02/2023).
More Related Videos
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Coronary Artery Disease III: Clinical Manifestations
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
Myocarditis III: Medical Management


